SEC Form 4 · accession 0001209191-16-147150
Dare Bioscience, Inc. · DARE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Eliasof
Officer — SVP, Chief Scientific Officer
Period of report
Oct 25, 2016
Accepted (ET)
Oct 27, 2016 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401914
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $0.8754 | Oct 25, 2016 | A | 10,000 | A | — | Oct 24, 2026 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1This option was granted on October 25, 2016. The shares underlying the option are subject to vest in equal monthly installments over four years from the grant date.